human-immunodeficiency-virus-hiv

Documents about human-immunodeficiency-virus-hiv

• GSK3640254 First Time in Human (FTIH) Study in Healthy Volunteers#906304ClinicalTrials.gov
• Veterans Living With HIV/AIDS: A Pilot Study Examining Risk Factors Associated With Self-Directed Violence#870109ClinicalTrials.gov
• National Multicenter Trial Evaluating Two Treatments in Patients With Primary Human Immunodeficiency Virus (HIV-1) Infection#882557ClinicalTrials.gov
• A Study to Evaluate Efficacy, Safety and Tolerability in Antiretroviral Therapy (ART)-Experienced Participants of at Least 50 Years of Age Living With Human Immunodeficiency Virus (HIV) With Virologic Suppression Who Switch to DTG/3TC FDC From BIC/FTC/TAF#874737ClinicalTrials.gov
• Friends for Life Circles for Option B Plus#808037ClinicalTrials.gov
• Safety and Immunogenicity Study of a Candidate Tuberculosis Vaccine in Human Immunodeficiency Virus (HIV)-Positive Adults#854281ClinicalTrials.gov
• Dose-finding Study of BMS-955176 to Treat HIV-1 Infected Treatment-naive Adults#857583ClinicalTrials.gov
• Improving Adherence Among HIV+ Rwandan Youth: A TI-CBTe Indigenous Leader Model#874835ClinicalTrials.gov
• Gut Microbiota-Mediated Inflammatory Interactions Between AUD and HIV Infection#1010144ClinicalTrials.gov
• GW640385 Plus Ritonavir And NRTIs For 48 Weeks In HIV-1 Infected Adults#864764ClinicalTrials.gov
• Short Course Intermittent Regimens for the Treatment of HIV-Associated Tuberculosis#803916ClinicalTrials.gov
• Digital Star: HIV Prevention for Youth in Mental Health Treatment#872985ClinicalTrials.gov
• The Effect of Antacids on the Pharmacokinetics (PK) of Raltegravir in Human Immunodeficiency Virus (HIV)-Infected Participants (MK-0518-824)#884923ClinicalTrials.gov
• EBV-positive mucocutaneous ulcer of the oral cavity associated with HIV/AIDS#649291University of Pretoria Repository
• A Study of MVA85A, in Asymptomatic Volunteers Infected With TB, HIV or Both#878772ClinicalTrials.gov
• Problems With Immune Recovery in the Gut Tissue#802231ClinicalTrials.gov
• BRIDGE: Improving HIV Service Delivery for People Who Inject Drugs#881819ClinicalTrials.gov
• Gene Expression Outcomes in Interventions for Substance Using HIV+ Minority Men#886694ClinicalTrials.gov
• Pediatric Enhanced Surveillance Study#916114ClinicalTrials.gov
• Impact of Representative Payee Services on ART Adherence Among Marginalized People Living With HIV/AIDS#968451ClinicalTrials.gov
• ING200336, Pharmacokinetic and Safety Study in Pregnant Women With Human Immuno Virus Infection#905895ClinicalTrials.gov
• A Drug-Drug Interaction Study of MK 8527 With a Combined Oral Contraceptive (LNG/EE)#855738ClinicalTrials.gov
• Pharmacokinetics of Intracellular TFV-DP and FTC-TP in HIV-infected Adolescents#870822ClinicalTrials.gov
• MMF for HIV Reservoir Reduction#886637ClinicalTrials.gov
• Study of Nevirapine and Prednisone to Determine the Safety and Effectiveness in Preventing Nevirapine Associated Rash in Human Immunodeficiency Virus (HIV) Infected Patients#894390ClinicalTrials.gov
• Switching Nevirapine Immediate Release( IR) Based Regimen to Nevirapine Extended Release (XR) Based Regimen in Human Immunodeficiency Virus One (HIV-1) Infected Patients#903749ClinicalTrials.gov
• Hepatic Safety of Eviplera® in HIV/Hepatitis C (HCV)-Coinfected Patients Without HCV Treatment in the "The HEPAVIR HEPATIC SAFETY Cohort."#891973ClinicalTrials.gov
• Dose-finding Study of GSK2248761 in Antiretroviral Therapy-experienced Subjects With NNRTI-resistant HIV Infection#1030571ClinicalTrials.gov
• Inhalation/Nasal Corticosteroids and Prevalence of Hypothalamic-pituitary-adrenal (HPA) Axis Suppression in Human Immunodeficiency Virus (HIV)-Patients#287442ClinicalTrials.gov
• Effect of Bednets and a Water Purification Device on HIV Disease Progression Among ART naïve Patients in Kenya#136391ClinicalTrials.gov
• A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV#906493ClinicalTrials.gov
• A Relative Bioavailability and Food-Effect Study of GSK3640254 Tablet and Capsule Formulations in Healthy Participants#914808ClinicalTrials.gov
• Lenacapavir Intensification to Disrupt HIV Reservoirs in Virologically Suppressed People With HIV Receiving Antiretroviral Therapy#906387ClinicalTrials.gov
• Building Mobile HIV Prevention and Mental Health Support in Low-resource Settings#884491ClinicalTrials.gov
• A Study to Evaluate the Antiviral Effect, Safety and Tolerability of GSK3810109A in Viremic Human Immunodeficiency Virus (HIV)-1 Infected Adults#904398ClinicalTrials.gov
• Antiretroviral Therapy and Inflammatory and Coagulation Biomarkers: iMACS Study#463606ClinicalTrials.gov
• POC Strategies to Improve TB Care in Advanced HIV Disease#982265ClinicalTrials.gov
• Impact of Migration History and Social Conditions on the Immuno-virological Control of HIV in Migrants in France#807745ClinicalTrials.gov
• A Study to Evaluate the Effect of Famotidine and Omeprazole on MK0518 (Raltegravir) Pharmacokinetics in Human Immunodeficiency Virus (HIV)-Infected Patients (0518-054)#902000ClinicalTrials.gov
• Study to Evaluate the Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Alafenamide in Human Immunodeficiency Virus (HIV-1) Infected, Antiretroviral Treatment-Naive Adults#979615ClinicalTrials.gov
• A Clinical Trial of MK-8527 and Rifampin in Adult Participants With Latent Tuberculosis Infection (MK-8527-019)#806187ClinicalTrials.gov
• A Phase I Study of T-Cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases SB-728mR in HIV-Infected Patients#895811ClinicalTrials.gov
• CSP #512 - Options in Management With Anti-Retrovirals#915324ClinicalTrials.gov
• Dolutegravir/Rilpivirine, Antiretroviral Efficacy Study Using Real-world Data in Subjects With Human Immunodeficiency Virus (HIV)-1#917827ClinicalTrials.gov
• Nevirapine Dosing in Neonates for Prophylaxis of Mother-to-Child-Transmission (MTCT) of HIV Infection#992624ClinicalTrials.gov
• Address by Dr Mahmoud Fikri Regional Director WHO Eastern Mediterranean Region to the Middle East and North Africa Regional co-sponsors meeting, Cairo, Egypt, 11 April 2017#286823WHO IRIS
• Evolution of Human Immunodeficiency Virus Type 1 Clade C Envelope V1–V5 Region during Disease Progression in Non-Human Primate Model#982861DigitalCommons@University of Nebraska
• Postexposure prophylaxis for HIV among healthcare workers in Türkiye: a descriptive, multicenter retrospective study#348459Recep Tayyip Erdoğan University Institutional Repository
• The Tolerability of, and Adherence to, Dolutegravir With Co-formulated Tenofovir-emtricitabine for HIV Non-occupational Post-exposure Prophylaxis#800468ClinicalTrials.gov
• Computer-based Intervention for Alcohol-using HIV/HCV+ Women#836037ClinicalTrials.gov